|
|
|
Volumn 59, Issue 2, 2001, Pages 301-307
|
|
Indication of H. pylori eradication therapy--who should be treated?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CLINICAL TRIAL;
HELICOBACTER INFECTION;
HELICOBACTER PYLORI;
HUMAN;
JAPAN;
MICROBIOLOGY;
MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA;
PEPTIC ULCER;
PRACTICE GUIDELINE;
REVIEW;
RISK;
STOMACH TUMOR;
CLINICAL TRIALS;
HELICOBACTER INFECTIONS;
HELICOBACTER PYLORI;
HUMANS;
JAPAN;
LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE;
PEPTIC ULCER;
PRACTICE GUIDELINES;
RISK;
STOMACH NEOPLASMS;
|
|
EID: 0035260577
PISSN: 00471852
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (2)
|
|
References (34)
|
